Persistent Asset Partners’s Insmed INSM Stock Holding History

Persistent Asset Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-142	Closed	-$20.3K	–	399
2025 Q4	$20.3K	Buy	+142	New	+$25.9K	0.01%	313

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Persistent Asset Partners's INSM Position: Q1 2026 in Review

Persistent Asset Partners sold out of Insmed (INSM) in Q1 2026, closing a stake of 3,692 shares — an estimated $643K sold.

Persistent Asset Partners first reported a position in INSM in Q4 2024 and held it in 3 quarters. The position peaked at $957K in Q4 2024. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Persistent Asset Partners reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
Persistent Asset Partners sold 3,692 Insmed shares in Q1 2026, an estimated $643K.
Persistent Asset Partners first reported a position in Insmed in Q4 2024 and held it in 3 quarters.
Persistent Asset Partners's Insmed position peaked at $957K in Q4 2024.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.